2022 - Research.com Best Scientist Award
His primary scientific interests are in Internal medicine, Transplantation, Surgery, Gastroenterology and Immunology. His Internal medicine study frequently draws connections between related disciplines such as Oncology. His work carried out in the field of Transplantation brings together such families of science as Regimen, Transplantation Conditioning and Bone marrow.
Richard E. Champlin has included themes like Stem cell and Rituximab in his Surgery study. His study focuses on the intersection of Gastroenterology and fields such as Imatinib mesylate with connections in the field of Vincristine, Philadelphia chromosome and Acute lymphocytic leukemia. The concepts of his Immunology study are interwoven with issues in Cytotoxic T cell, Disease and Pneumonia.
Richard E. Champlin mainly investigates Internal medicine, Transplantation, Surgery, Hematopoietic stem cell transplantation and Gastroenterology. His study on Internal medicine is mostly dedicated to connecting different topics, such as Oncology. His Transplantation research incorporates elements of Leukemia, Immunology, Bone marrow and Stem cell.
His biological study spans a wide range of topics, including Preparative Regimen and Multiple myeloma. His work deals with themes such as Survival rate, Transplantation Conditioning, Retrospective cohort study and Univariate analysis, which intersect with Hematopoietic stem cell transplantation. His Gastroenterology research is multidisciplinary, incorporating perspectives in Chemotherapy regimen, Tacrolimus, Cumulative incidence, Rituximab and ThioTEPA.
His primary areas of study are Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Gastroenterology. In his study, Minimal residual disease is strongly linked to Surgery, which falls under the umbrella field of Internal medicine. His study on Transplantation also encompasses disciplines like
His Oncology research focuses on subjects like Leukemia, which are linked to Myeloid and Survival rate. His studies in Hematopoietic stem cell transplantation integrate themes in fields like Incidence, Retrospective cohort study, Transplantation Conditioning, Cohort and Acute leukemia. His Gastroenterology study combines topics from a wide range of disciplines, such as Methotrexate and Cumulative incidence.
Richard E. Champlin mostly deals with Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Oncology and Immunology. His Internal medicine study incorporates themes from Gastroenterology and Surgery. In the field of Surgery, his study on Clinical endpoint overlaps with subjects such as Adenine nucleotide.
His studies deal with areas such as Regimen, Cyclophosphamide, Fludarabine and Stem cell as well as Transplantation. The various areas that he examines in his Hematopoietic stem cell transplantation study include Incidence, Graft-versus-host disease, Transplantation Conditioning and Autologous stem-cell transplantation, Multiple myeloma. His Oncology research incorporates themes from Cancer, Survival rate, Myelodysplastic syndromes, Leukemia and Survival analysis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
R H Collins;O Shpilberg;W R Drobyski;D L Porter.
Journal of Clinical Oncology (1997)
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
Sergio Giralt;Elihu Estey;Maher Albitar;Koen Van Besien.
Bone Marrow-derived Mesenchymal Stem Cells as Vehicles for Interferon-β Delivery into Tumors
Matus Studeny;Frank C. Marini;Richard E. Champlin;Claudia Zompetta.
Cancer Research (2002)
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.
Martin Körbling;Ruth L. Katz;Abha Khanna;Arnout C. Ruifrok.
The New England Journal of Medicine (2002)
Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents
Matus Studeny;Frank C. Marini;Jennifer L. Dembinski;Claudia Zompetta.
Journal of the National Cancer Institute (2004)
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
Mary Eapen;Pablo Rubinstein;Mei Jie Zhang;Cladd Stevens.
The Lancet (2007)
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
Sergio Giralt;Peter F. Thall;Issa Khouri;Xuemei Wang.
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
Ernest S. Kawasaki;Steven S. Clark;Mazie Y. Coyne;Stephen D. Smith.
Proceedings of the National Academy of Sciences of the United States of America (1988)
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
Jeffrey J. Molldrem;Peter P. Lee;Changqing Wang;Kyrie Felio.
Nature Medicine (2000)
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation
Richard E. Champlin;Norbert Schmitz;Mary M. Horowitz;Bernard Chapuis.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: